2019年第一季度我国医药工业经济运行情况分析

Economic operation of Chinese pharmaceutical industry in the first quarter of 2019

2019年一季度,我国医药工业主要经济指标增速均有所下滑,营业收入增速呈下滑趋势持续走低,增速跌至10.4%,是近2年来的最低水平。利润总额增速呈大幅度的持续下滑趋势,跌至11.1%,是近3年来的最低水平。规模以上医药制造业增加值累计同比增速有所减缓,医药制造业固定资产投资额同比大幅上升,行业进入新一轮投资期。出口交货值增长较缓,且出口贸易结构正在调整中,呈现向好态势。

In the first quarter of 2019,the growth rate of the main economic indicators of China’s pharmaceutical industry decreased.The growth rate of business income continued to decline,falling to 10.4%,which was the lowest level in the recent two years.The gross profit growth showed a significant and sustained downward trend,falling to 11.1%,which was the lowest level in the last three years.The cumulative growth rate of added value of pharmaceutical manufacturing industry above the scale has slowed down compared with that in the same period of last year,the growth rate of the pharmaceutical manufacturing investment in fixed assets has risen sharply,and the industry entered a new round of investment period.The export value was growing slowly,and the structure of export trade was being adjusted,which showed a positive trend.